Meagan Ethridge
Acute Care · Suffolk, VANPI 1023817269
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations.
Across 85 payments — averaging $25.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$285
- Novartis$167
- Sanofi$146
- Daiichi Sankyo Inc.$141
- Incyte Corporation$97
- Gilead$95
- plus $1K from 30 others
What the payments were for
- Food & beverage$1,96492%
- Education$1798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $285 |
| Novartis | 6 | $167 |
| Sanofi | 5 | $146 |
| Daiichi Sankyo Inc. | 8 | $141 |
| Incyte Corporation | 4 | $97 |
| Gilead | 2 | $95 |
| AstraZeneca(2 entities) | 4 | $94 |
| E.r. Squibb & Sons, L.L.C. | 4 | $80 |
| Merck | 3 | $74 |
| Sobi, Inc | 3 | $70 |
| AbbVie | 3 | $69 |
| Servier Pharmaceuticals LLC | 3 | $66 |
| Tersera Therapeutics LLC | 2 | $65 |
| Bayer | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Pfizer | 2 | $45 |
| Boehringer Ingelheim | 2 | $43 |
| Puma Biotechnology, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| Immunocore Limited | 1 | $36 |
| Jazz Pharmaceuticals Inc. | 1 | $36 |
| Beone Medicines USA, Inc. | 1 | $31 |
| Taiho Oncology, Inc. | 1 | $29 |
| Legend Biotech USA Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Caris MPI, Inc. | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Adaptive Biotechnologies Corporation | 1 | $24 |
| Exelixis Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| GSK | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Geron Corporation | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,143 in reported general payments places this provider in the 80th percentile of 599 acute care providers in Virginia.
Other acute care in Suffolk
- Scott AverySuffolk$5K
- Zia KhouldSuffolk$3K
- Rachel DukeRichmond$751K
- Julia KingNorfolk$99K
- Sarah KennedyNorfolk$57K
- Sarah W ShermanNorth Chesterfield$41K
- Tamara StephensDeltaville$30K
- Debra CastnerNassawadox$28K
- Linda HartMidlothian$21K
- Mica FerlisRichmond$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.